E2F1 and glioma: HOTAIR has been identified as a potential biomarker for glioma subtypes and tumor grades, with its silencing in glioblastoma cell lines (LN229 and U87) shown to disrupt cell cycle regulation by downregulating E2F1, cyclins, CDKs while upregulating inhibitors p16 and p21 [94].